Trypsin Disrupts the Trafficking of the Human Dopamine Transporter by α-Synuclein and Its A30P Mutant
- 14 January 2004
- journal article
- Published by American Chemical Society (ACS) in Biochemistry
- Vol. 43 (5) , 1242-1253
- https://doi.org/10.1021/bi035308s
Abstract
Alpha-synuclein modulates dopamine homeostasis in dopamine-producing neurons of substantia nigra, partly through regulation of human dopamine transporter (hDAT) activity. To identify the underlying mechanisms, we disrupted the modulation of hDAT activity by wild-type (wt) alpha-synuclein, and its familial Parkinson's disease linked mutants A30P and A53T, by mild trypsinization (0.1%, 30 s) of Ltk(-) cotransfected cells. Trypsin completely reversed the attenuation of hDAT function mediated by wt and the A30P mutant. In A53T coexpressing cells, where DAT activity is not downregulated, trypsinization did not induce any changes. These effects of trypsin were mimicked by collagenase I and Dispase (0.1%, 1 min each) but not by chymotrypsin, Pronase, or papain (0.1%, up to 2 min each). Trypsin increased dopamine uptake in rat primary mesencephalic neurons, suggesting that DAT activity is also subjected to modulation by alpha-synuclein in these neurons that endogenously coexpress both proteins. In trypsinized cells, dopamine accelerated both production of reactive oxygen species and cell death in hDAT and wt or A30P, but not A53T, coexpressing cells, compared to nontrypsinized cells. Paradoxically, trypsin increased the protein-protein interactions between the synuclein variants and hDAT, without any noticeable proteolysis of these proteins. hDAT-alpha-synuclein protein-protein interactions occurred through residues 58-107 (NAC domain) of the alpha-synuclein variants and residues 598-620 of the carboxy-terminal tail of hDAT, in both trypsinized and nontrypsinized cells. Confocal microscopy and biotinylation studies show that, in cells expressing the wt or A30P variants, but not the A53T mutant, hDAT is sequestered away from the plasma membrane into the cytoplasm, an effect that is reversed by trypsin. These results show that alpha-synuclein modulates hDAT function through trafficking of the transporter in a process that can be disrupted by trypsin.Keywords
This publication has 28 references indexed in Scilit:
- Mutations in the lipid-binding domain of α-synuclein confer overlapping, yet distinct, functional properties in the regulation of dopamine transporter activityMolecular and Cellular Neuroscience, 2003
- Modulation of dopamine transporter function by α‐synuclein is altered by impairment of cell adhesion and by induction of oxidative stressThe FASEB Journal, 2003
- Differential cytotoxicity of dopamine and H2O2 in a human neuroblastoma divided cell line transfected with α-synuclein and its familial Parkinson's disease-linked mutantsNeuroscience Letters, 2003
- α-Synuclein Lowers p53-dependent Apoptotic Response of Neuronal CellsPublished by Elsevier ,2002
- Pathogenesis of parkinson's disease: dopamine, vesicles and α-synucleinNature Reviews Neuroscience, 2002
- Effect of Mutant α-Synuclein on Dopamine Homeostasis in a New Human Mesencephalic Cell LineJournal of Biological Chemistry, 2002
- Age‐dependent differential regulation of genes encoding APP and α‐synuclein in hippocampal synaptic plasticityHippocampus, 2002
- Interaction of α‐synuclein and synphilin‐1: effect of Parkinson's disease‐associated mutationsJournal of Neurochemistry, 2001
- Physiology and Pathophysiology of α‐Synuclein: Cell Culture and Transgenic Animal Models Based on a Parkinson's Disease‐associated ProteinAnnals of the New York Academy of Sciences, 2000
- The α‐Synucleinopathies: Parkinson's Disease, Dementia with Lewy Bodies, and Multiple System AtrophyAnnals of the New York Academy of Sciences, 2000